0000876661-12-000620.txt : 20121005
0000876661-12-000620.hdr.sgml : 20121005
20121005155542
ACCESSION NUMBER: 0000876661-12-000620
CONFORMED SUBMISSION TYPE: 25-NSE
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20121005
DATE AS OF CHANGE: 20121005
EFFECTIVENESS DATE: 20121005
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: PAR PHARMACEUTICAL COMPANIES, INC.
CENTRAL INDEX KEY: 0000878088
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 223122182
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10827
FILM NUMBER: 121132390
BUSINESS ADDRESS:
STREET 1: 300 TICE BOULEVARD
CITY: WOODCLIFF LAKE
STATE: NJ
ZIP: 07677
BUSINESS PHONE: 201-802-4000
MAIL ADDRESS:
STREET 1: 300 TICE BOULEVARD
CITY: WOODCLIFF LAKE
STATE: NJ
ZIP: 07677
FORMER COMPANY:
FORMER CONFORMED NAME: PHARMACEUTICAL RESOURCES INC
DATE OF NAME CHANGE: 19940526
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: NEW YORK STOCK EXCHANGE LLC
CENTRAL INDEX KEY: 0000876661
IRS NUMBER: 000000000
STATE OF INCORPORATION: NY
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: 11 WALL STREET
CITY: NEW YORK
STATE: NY
ZIP: 10005
BUSINESS PHONE: 212-656-2060
MAIL ADDRESS:
STREET 1: 11 WALL STREET
CITY: NEW YORK
STATE: NY
ZIP: 10005
FORMER COMPANY:
FORMER CONFORMED NAME: NEW YORK STOCK EXCHANGE INC
DATE OF NAME CHANGE: 19910628
25-NSE
1
primary_doc.xml
X0203
0000876661
NEW YORK STOCK EXCHANGE LLC
0000878088
PAR PHARMACEUTICAL COMPANIES, INC.
001-10827
300 TICE BOULEVARD
WOODCLIFF LAKE
NJ
NEW JERSEY
07677
201-802-4000
Rights to Purchase Series A Junior Participating Preferred Stock, $0.0001 per share
17 CFR 240.12d2-2(a)(4)
Paras Madho
Director
2012-10-05
EX-99.25
2
prxrights.htm
NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED
SECURITIES
The New York Stock Exchange hereby notifies the SEC of its intention to remove
the entire class of the stated securities from listing and registration on the
Exchange at the opening of business on October 16, 2012, pursuant to the
provisions of Rule 12d2-2 (a).
[ X ] 17 CFR 240.12d2-2(a)(4) That the entire class of this security was
terminated on October 1, 2012.
The removal of the Rights to Purchase Series A Junior Participating Preferred
Stock, $0.0001 per share of Par Pharmaceutical Companies, Inc. is being
effected because the Exchange knows or is reliably informed that on October 1,
2012 all rights pertaining to the entire class of this security were
extinguished.
The Exchange also notifies the Securities and Exchange Commission that as a
result of the above indicated conditions this security was suspended on
October 1, 2012.